Grave's Disease
Showing 1 - 25 of >10,000
Evaluation of Patients With Thyroid Disorders
Recruiting
- Hyperthyroidism
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Alzheimer's Disease Trial in Toulouse (NanoLithium® NP03, Placebo)
Recruiting
- Alzheimer's Disease
- NanoLithium® NP03
- Placebo
-
Toulouse, FranceCHU Toulouse - Hôpital La Grave - Cité de la Santé
Jun 14, 2022
Alzheimer Trial in France, Germany, Spain (ACC-001(3µg) + QS21, ACC-001(10µg) + QS21, ACC-001(30µg) + QS21)
Completed
- Alzheimer Disease
- ACC-001(3µg) + QS21
- +2 more
-
Bordeaux Cedex, France
- +16 more
Mar 1, 2021
Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)
Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)
Recruiting
- Thyroid Eye Disease
- Graves Orbitopathy
- Secukinumab
- Placebo
-
Essen, Germany
- +6 more
Jul 14, 2022
Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)
Recruiting
- Alzheimer Disease
- +2 more
- JNJ-63733657
- Placebo
-
Birmingham, Alabama
- +143 more
Jan 31, 2023
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Chronic Kidney Diseases, Obesity, Overweight Trial in Ljubljana (Cognitive Behavioral Therapy (CBT) for managing Obesity)
Recruiting
- Chronic Kidney Diseases
- +2 more
- Cognitive Behavioral Therapy (CBT) for managing Obesity
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Jun 21, 2023
Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid
Recruiting
- Autoimmune Thyroid Disease
-
Jinan, Shandong, ChinaShandong Province Hospital
Apr 12, 2021
MDD Trial in France (Transcultural psychotherapy)
Not yet recruiting
- Major Depressive Disorder
- Transcultural psychotherapy
-
Bobigny, France
- +5 more
Mar 12, 2020
Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)
Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)
Thyroglobulin Point of Care Assay for Rapid Detection of
Recruiting
- Differentiated Thyroid Cancer
- Lymph Node Metastases
- Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
-
Ashkelon, Israel
- +2 more
Oct 25, 2022
Pediatric Eye Care Investigated Team
Not yet recruiting
- Eye Diseases
- +3 more
- (no location specified)
Feb 8, 2022
Intracerebral Hemorrhage Trial in Szczecin (Atorvastatin, Rosuvastatin, No drugs)
Completed
- Intracerebral Hemorrhage
- Atorvastatin
- +2 more
-
Szczecin, West Pomeranian, PolandPomeranian Medical University
Oct 16, 2023
Survey of Patients With Idiopathic Orbital Inflammation Syndrome
Completed
- Orbital Ischemic Syndrome
- Orbital Pseudotumor
-
Bobigny, FranceService de Médecine interne - Hôpital Avicenne
Nov 19, 2021
Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)
Heart Failure in a High-Risk Diabetic Cohort
Recruiting
- Type2diabetes
- heart failure risk factors
-
Taipei, TaiwanMackay Memorial Hospital
May 17, 2023
Comorbidities in Alopecia Areata in Czech Republic
Active, not recruiting
- Alopecia Areata
- +26 more
- Exposure of interest
-
Prague, CzechiaTeaching Hospital of Royal Vineguards
Oct 30, 2021
Associated Burden of Related Conditions in Alopecia Areata
Completed
- Alopecia Areata
- +35 more
- Exposure of interest (studies 2 & 3).
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Hyperthyroidism, Autoimmune Trial in Spain (Lugols Strong Iodine)
Recruiting
- Hyperthyroidism, Autoimmune
- Lugols Strong Iodine
-
Hospitalet de Llobregat, Barcelona, Spain
- +20 more
Jul 4, 2021
Arrest, Bone, Development Trial in Lahore (Propranolol, Nandrolone Decanoate)
Recruiting
- Arrest
- +3 more
- Propranolol
- Nandrolone Decanoate
-
Lahore, Punjab, PakistanKing Edward Medical University, Mayo Hospital
Mar 27, 2023
the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in
Recruiting
- Oral Lichen Planus
- Oral Cancer
-
Cairo, Egypt
- +1 more
Jan 23, 2023
Valvular Heart Disease Trial in Germany, Latvia, Poland (cerebral embolic protection during TAVR)
Recruiting
- Valvular Heart Disease
- cerebral embolic protection during TAVR
-
Trier, Rhineland-Palatinate, Germany
- +7 more
Sep 26, 2022
CKD, Type 2 Diabetes Trial
Not yet recruiting
- CKD
- Type 2 Diabetes
- (no location specified)
Jan 11, 2023